Literature DB >> 17602186

Attention deficit hyperactivity disorder symptoms predict nicotine dependence and progression to regular smoking from adolescence to young adulthood.

Bernard F Fuemmeler1, Scott H Kollins, F Joseph McClernon.   

Abstract

OBJECTIVE: To examine the association between retrospectively reported attention deficit hyperactivity disorder (ADHD) symptoms and progression to smoking and the association with nicotine dependence.
METHODS: Study sample consisted of a nationally representative cohort of U.S. adolescents (n = 13,494). Logistic regression was used to examine ADHD symptoms from both the inattentive (IN) and hyperactive-impulsive (HI) domains and smoking trajectories. Linear regression was used to examine nicotine dependence.
RESULTS: HI symptoms were associated with progression from nonsmoking to regular smoking (OR = 1.14, 95% CI = 1.07-1.21), and with progression from experimentation to regular smoking (OR = 1.16, 95% CI = 1.08-1.26). IN and HI symptoms were associated with nicotine dependence among current smokers (IN: beta = 0.17, SE = 0.03, p < 0.0001; HI: beta = 0.10, SE = 0.04., p < .001).
CONCLUSIONS: These results have important implications for the development of prevention and treatment modalities.

Entities:  

Mesh:

Year:  2007        PMID: 17602186     DOI: 10.1093/jpepsy/jsm051

Source DB:  PubMed          Journal:  J Pediatr Psychol        ISSN: 0146-8693


  64 in total

1.  Adolescent cancer survivors' smoking intentions are associated with aggression, attention, and smoking history.

Authors:  Lisa S Kahalley; Vida L Tyc; Stephanie J Wilson; Jenna Nelms; Melissa M Hudson; Shengjie Wu; Xiaoping Xiong; Pamela S Hinds
Journal:  J Cancer Surviv       Date:  2010-10-05       Impact factor: 4.442

2.  Smoking behaviors and attitudes during adolescence prospectively predict support for tobacco control policies in adulthood.

Authors:  Jonathan T Macy; Laurie Chassin; Clark C Presson
Journal:  Nicotine Tob Res       Date:  2011-12-21       Impact factor: 4.244

Review 3.  Mouse models for studying genetic influences on factors determining smoking cessation success in humans.

Authors:  F Scott Hall; Athina Markou; Edward D Levin; George R Uhl
Journal:  Ann N Y Acad Sci       Date:  2012-02       Impact factor: 5.691

4.  Nicotine Addiction and Psychiatric Disorders.

Authors:  Munir Gunes Kutlu; Vinay Parikh; Thomas J Gould
Journal:  Int Rev Neurobiol       Date:  2015-09-19       Impact factor: 3.230

5.  Durability and generalizability of time-based intervention effects on impulsive choice in rats.

Authors:  Carrie Bailey; Jennifer R Peterson; Aaron Schnegelsiepen; Sarah L Stuebing; Kimberly Kirkpatrick
Journal:  Behav Processes       Date:  2018-03-12       Impact factor: 1.777

6.  Methylphenidate does not influence smoking-reinforced responding or attentional performance in adult smokers with and without attention deficit hyperactivity disorder (ADHD).

Authors:  Scott H Kollins; Erin Schoenfelder; Joseph S English; F Joseph McClernon; Rachel E Dew; Scott D Lane
Journal:  Exp Clin Psychopharmacol       Date:  2013-10       Impact factor: 3.157

Review 7.  ADHD and smoking: from genes to brain to behavior.

Authors:  Francis Joseph McClernon; Scott Haden Kollins
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

8.  Relationship between cigarette smoking and childhood symptoms of inattention and hyperactivity/impulsivity in alcohol-dependent adults without attention-deficit hyperactivity disorder.

Authors:  Jaimee L Heffner; Candace S Johnson; Thomas J Blom; Robert M Anthenelli
Journal:  Nicotine Tob Res       Date:  2010-01-18       Impact factor: 4.244

9.  Symptom dimensions of attention deficit hyperactivity disorder and nicotine withdrawal symptoms.

Authors:  Katherine J Ameringer; Adam M Leventhal
Journal:  J Addict Dis       Date:  2012

10.  Effects of smoking abstinence on smoking-reinforced responding, withdrawal, and cognition in adults with and without attention deficit hyperactivity disorder.

Authors:  Scott H Kollins; Joseph S English; Michelle E Roley; Benjamin O'Brien; Justin Blair; Scott D Lane; F Joseph McClernon
Journal:  Psychopharmacology (Berl)       Date:  2012-12-18       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.